HOME >> BIOLOGY >> NEWS
BioMed Central to consider charging authors for paper submissions

BioMed Central http://www.biomedcentral.com, the online publishing company committed to providing free access to the scientific research it publishes, is considering levying author charges for published articles as a means of covering publication costs.

The company is currently assessing the possibility of charging a moderate fee of about $500 for publication. Authors would only be charged at the time of publication and would not be charged for rejected papers. These fees would also be waived selectively for authors who have difficulties with funding or are from regions with limited research budgets.

Whilst BioMed Central would be pioneering author charges of this type, a number of journal publishers already levy page charges and there are a multitude of hidden publication costs - i.e: fees for colour plates and diagrams. These are often much more then $500.

By paying a moderate charge to cover the cost of publication, which in turn will fund open access, scientists will be contributing to a system that is revolutionizing the way in which research is shared. Open access will allow for the wide and immediate dissemination of research findings and will minimize the amount of funding needed to cover journal subscription fees, thereby reducing the cost to the academic community as a whole.

The scientific research community in the form of the Public Library of Science (PLoS) Advocacy Group (http://www.publiclibraryofscience.org/), which is challenging publishers to offer open access to their research, considers author charges as a viable way of covering publication costs.

Mike Eisen, Assistant Adjunct Professor of Genetics and Development at Berkeley and supporter of PLoS, commented:

'Author charges that completely cover the costs of reviewing, editing and publishing scientific manuscripts and result in immediate and complete free access are an excellent way for scientists and
'"/>

Contact: Gordon Fletcher
gordon@biomedcentral.com
44-0-7323-0323
BioMed Central
13-Jul-2001


Page: 1 2

Related biology news :

1. BioMed Central to consult funders and librarians over Open Access payment model
2. LA BioMed Medical/Research Briefs, July/August 2004
3. BioMed Central explodes Open Access myths
4. The Scientist and BioMed Central come together to publish high-impact magazine
5. BioMed Central is pleased to announce the publication of Sydney Brenners autobiography
6. BioMed Central to deposit e-journals with the British Library
7. Get Research on the move with BioMed Central
8. BioMed Central to launch at microbiology meeting
9. BioMed Central to free scientists and clinical researchers from copyright restrictions
10. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
11. Sediments in many Central Valley streams contain toxic levels of pyrethroid pesticides

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 18, 2019 , ... ... Meredith James, HT, PMP, to its executive team as Vice President of Operations. ... drug development. In her new role, Ms. James is responsible for ensuring on-time ...
(Date:7/17/2019)... ... 15, 2019 , ... RCH Solutions (RCH), a ... companies, announces the availability of new specialty advisory practice, a Public Cloud Managed ... emerging bio-pharma companies interested in achieving specific outcomes related to public Cloud adoption. ...
(Date:7/17/2019)... ... ... Imagine using a simple, portable test to detect cancer before malignant tissues ... South Dakota School of Mines & Technology researcher Congzhou Wang, Ph.D., these ideas are ... to monitor and prevent disease,” says Wang. , Wang, an assistant professor in ...
Breaking Biology News(10 mins):
(Date:7/26/2019)... ... July 25, 2019 , ... LeadingBiotech , an exclusive ... announces its Boston BD conference to be held on September 10, ... Boston , the event provides an opportunity for attendees to leverage insight from ...
(Date:7/17/2019)... , ... July 16, 2019 ... ... long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), ... this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space at ...
(Date:7/2/2019)... ... July 02, 2019 , ... Leading Regenerative Veterinary Medicine company, ... Where Beasts Meet Biotech. The film focuses on regenerative veterinary medicine as a ... Pharm was recently included in the Brentwood and Pacific Palisades International Film ...
(Date:6/11/2019)... ... June 10, 2019 , ... Thought Technology Ltd is ... of Biofeedback Tech Ltd as its authorised distributor for the UK ... many therapeutic treatments and clinical assessment protocols to treat stress related disorders as ...
Breaking Biology Technology:
Cached News: